Goldman Sachs’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,112
| Closed | -$182K | – | 5009 |
|
|
2023
Q4 | $182K | Buy |
18,112
+2,132
| +13% | +$21.4K | ﹤0.01% | 4354 |
|
|
2023
Q3 | $46K | Sell |
15,980
-1,274
| -7% | -$3.67K | ﹤0.01% | 4491 |
|
|
2023
Q2 | $65.7K | Sell |
17,254
-215
| -1% | -$819 | ﹤0.01% | 4634 |
|
|
2023
Q1 | $32.5K | Sell |
17,469
-2,992
| -15% | -$5.57K | ﹤0.01% | 4827 |
|
|
2022
Q4 | $47.1K | Sell |
20,461
-2,858
| -12% | -$6.57K | ﹤0.01% | 4797 |
|
|
2022
Q3 | $75K | Sell |
23,319
-959
| -4% | -$3.08K | ﹤0.01% | 4979 |
|
|
2022
Q2 | $134K | Sell |
24,278
-80,141
| -77% | -$442K | ﹤0.01% | 5025 |
|
|
2022
Q1 | $243K | Buy |
104,419
+86,500
| +483% | +$201K | ﹤0.01% | 4991 |
|
|
2021
Q4 | $108K | Buy |
+17,919
| New | +$108K | ﹤0.01% | 5200 |
|